Cochrane Abstracts
Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Certolizumab Pegol for Maintenance of Medically Induced Remission in Crohn’s disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435915/all/Surfactant_for_bacterial_pneumonia_in_late_preterm_and_term_infants:_Cochrane_systematic_review. Accessed 18 April 2024.
Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435915/all/Surfactant_for_bacterial_pneumonia_in_late_preterm_and_term_infants:_Cochrane_systematic_review. Accessed April 18, 2024.
Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435915/all/Surfactant_for_bacterial_pneumonia_in_late_preterm_and_term_infants:_Cochrane_systematic_review
Certolizumab Pegol for Maintenance of Medically Induced Remission in Crohn’s disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435915/all/Surfactant_for_bacterial_pneumonia_in_late_preterm_and_term_infants:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease
ID - 435915
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435915/all/Surfactant_for_bacterial_pneumonia_in_late_preterm_and_term_infants:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
